Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
audiogram
auditory and vestibular pathways
carbamazepine
dantrolene sodium
demyelinating disease
diet
dilantin
droperidol
fasciculation
genetic neurologic disorders
guanidine
hearing loss
hyperhidrosis
Isaacs syndrome
meclizine
multiple sclerosis
multiple sclerosis, diagnosis of
multiple sclerosis, diet in
multiple sclerosis, differential diagnosis of
multiple sclerosis, etiology of
multiple sclerosis, linoleic acid in
multiple sclerosis, treatment of
muscle atrophy, static
muscle pain
muscle stiffness
muscle weakness
myasthenic syndrome
myasthenic syndrome, treatment of
myokymia
neuromyotonia
neuropathy, peripheral
neurosyphilis
Parkinson disease
primrose oil
sinemet
steroid therapy, CNS treatment and complications with
sweating
sweating, abnormality of
syphilis, neurologic complications with
treatment of neurologic disorder
valium
vertigo
vertigo, cervical
vertigo, treatment of
Showing articles 1200 to 1250 of 5061 << Previous Next >>

Orbital and Optic Pathway Sarcoidosis:MR Findings
AJNR 15:775-783, Carmody,R.F.,et al, 1994

Cerebrospinal Fluid in the Diagnosis of Multiple Sclerosis:A consensus Report
JNNP 57:897-902, Andersson,M.,et al, 1994

Antiphospholipid Antibody Syndrome Mimicking Multiple Sclerosis Clinically and by Magnetic Resonance Imaging
Arch Int Med 154:917-920, Scott,T.F.,et al, 1994

Leber's Hereditary Optic Neuropathy Mitochondrial DNA Mutations in Multiple Sclerosis
Ann Neurol 36:109-112, Kellar-Wood,H.,et al, 1994

Uhthoff's Symptom in Disorders of the Anterior Visual Pathways
Neurol 44:1036-1038, Lepore,F.E., 1994

Neuroanatomy of Fragile X Syndrome:The Temporal Lobe
Neurol 44:1317-1324, Reiss,A.L.,et al, 1994

Reduced Basal Ganglia Volume Associated with the Gene for Huntington's Disease in Asymptomatic at-Risk Persons
Neurol 44:823-828, Aylward,E.H.,et al, 1994

The Use of Brain Magnetic Resonance Imaging in Multiple Sclerosis
Arch Neurol 51:505-516, Goodkin,D.E.,et al, 1994

Benign Form of Multiple Sclerosis:MRI Evidence for Less Frequent and Less Inflammatory Disease Activity
JNNP 57:1070-1072, Kidd,D.,et al, 1994

Quantitative Brain MRI Lesion Load Predicts the Course of Clinically Isolated Syndromes Suggestive of Multiple Sclerosis
Neurol 44:635-641, Felippi,M.,et al, 1994

Extent of Pontine Pyramidal Tract Wallerian Degeneration and Outcome after Supratentorial Hemorrhagic Stroke
Stroke 25:1207-1210, Fukui,K.,et al, 1994

The British Isles Survey of Multiple Sclerosis in Twins
Neurol 44:11-15, Mumford,C.J.,et al, 1994

Treatment of Paroxysmal Symptoms in Multiple Sclerosis with Ibuprofen
Neurol 44:571-572, Khan,O.A., 1994

Magnetic Resonance Evaluation of Disease Activity During Pregnancy in Multiple Sclerosis
Neurol 44:327-329, vanWalderveen,M.A.A.,et al, 1994

Concentric Sclerosis (Balo) :Morphometric and In Situ Hybridization Study of Lesions in Six Patients
Ann Neurol 35:18-30, Yao,D-L.,et al, 1994

Serial Neurologic Examinations After Near Drowning and Outcome
Arch Pediatr Adolesc Med 148:167-170, Bratton,S.L.,et al, 1994

A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
NEJM 330:585-591, Bensimon,G.,et al, 1994

Megadose Corticosteroids in Multiple Sclerosis
Neurol 44:1-4, Kupersmith,M.J.,et al, 1994

Spontaneous Palpebromandibular Synkinesia:A Localizing Clinical Sign
Ann Neurol 35:222-228, Pullicino,P.M.,et al, 1994

Chronic Spinal Cord Injury
NEJM 330:550-556, Ditunno,J.F.&Formal,C.S., 1994

A Randomized Trial of Test Result Sequencing in Patients with Suspected Multiple Sclerosis
Arch Neurol 51:53-59, O'Connor,P.,et al, 1994

Value of Magnetic Resonance Imaging-Based Measurements of Hippocampal Formations in Patients with Partial Epilepsy
Arch Neurol 51:130-138, Adam,C.,et al, 1994

Patent Foramen Ovale and Brain Infarct:Echocardiographic Predictors, Recurrence, and Prevention
Stroke 25:782-786, Hanna,J.P.,et al, 1994

Prognosis of Young Adults with Ischemic Stroke:Follow-up Assessing Recurrent Vascular Events & Funct Outcome
Stroke 25:1360-1365, Kappelle,L.J.,et al, 1994

Interrater Agreement in Evaluation of Stroke Patients with the Unified Neurological Stroke Scale
Stroke 25:1263-1264, Treves,T.A.,et al, 1994

Deep Gray Matter Involvement in Children with Acute Disseminated Encephalomyelitis
AJNR 15:1275-1283, Baum,P.A.,et al, 1994

Breast Feeding and Multiple Sclerosis
BMJ 308:1411-1412, Pisacane,A.,et al, 1994

Practice Advisory on Selection of Patients with Multiple Sclerosis for Treatment with Betaseron
Neurol 44:1537-1540, Alter,M.,et al, 1994

Are Magnetic Resonance Findings Pred of Clinical Outcome in Therapeutic Trials in MS? The Dilemma of Interferon-B
Ann Neurol 36:14-18, McDonald,W.I.,et al, 1994

The Effects of 4-Aminopyridine in MS Pts:Randomized, Placebo-Controlled, Double-Blind, Concentration-Controlled, Crossover
Neurol 44:1054-1059, Bever,C.T.,et al, 1994

Posttraumatic Headache
Semin Neurol 14:40-45, Packard,R.C., 1994

Mild Head Injury
(Ed) , Semin Neurol 14:1-9294., Packard,R.C., 1994

Regional Brain Abnormalities in Schizophrenia Measured with Magnetic Resonance Imaging
JAMA 272:1763-1769, Andreasen,N.C.,et al, 1994

Longitudinal MRI in Multiple Sclerosis:Correlation Between Disability and Lesion Burden
Neurol 44:2120-2124, Khoury,S.J.,et al, 1994

Detection of Cortical Neuron Loss in Motor Neuron Disease by Proton Magnetic Resonance Spectroscopic Imaging in Vivo
Neurol 44:1933-1938, Pioro,E.P.,et al, 1994

Growth Factors:Potential Therapeutic Applications in Neurology
JNNP 54:1445-1450, Drago,J.,et al, 1994

Tizanidine Treatment of Spasticity Caused by Multiple Sclerosis:Results of a Double-Blinded, Placebo-Controlled Trial
Neurol 44:S34-S43, Smith,C.,et al, 1994

A Double-Blind, Placebo-Controlled Trial of Tizanidine in the Treatment of Spasticity Caused by Multiple Sclerosis
Neurol 44:S70-S78, Barnes,M.P.,et al, 1994

Failure of Aspirin Treatment After Stroke
Stroke 25:275-277, Bornstein,N.M.,et al, 1994

Betaseron for Multiple Sclerosis:Implications for Therapeutics
Arch Neurol 51:125-128, Rudick,R., 1994

Chronic Systemic High-Dose Recombinant Interferon Alfa-2a Reduces Exacerbation Rate & MRI Signs in MS
Neurol 44:406-413, Durelli,L.,et al, 1994

Treatment of Multiple Sclerosis
Lancet 343:275-279, Ebers,G.C., 1994

4-Aminopyridine in the Treatment of Patients with Multiple Sclerosis:Long-term Efficacy and Safety
Arch Neurol 51:292-296, Polman,C.H.,et al, 1994

A Genetic Marker and Family History Study of the Upstate New York Multiple Sclerosis Cluster
Neurol 44:329-333, Schiffer,R.B.,et al, 1994

The Value of Diagnostic Information to Patients with Suspected Multiple Sclerosis
Arch Neurol 51:67-72, Mushlin,A.I.,et al, 1994

Effect of Diagnostic Testing for Multiple Sclerosis on Patient Health Perceptions
Arch Neurol 51:46-51, O'Connor,P.,et al, 1994

Pathogenesis of Multiple Sclerosis
Lancet 343:271-275, Ffrench-Constant,C., 1994

Takayasu Arteritis
Ann Int Med 120:919-929, Kerr,G.S.,et al, 1994

Movement Disorders Following Lesions of the Thalamus or Subthalamic Region
Mov Disord 9:493-507, Lee,M.S. &Marsden, C.D., 1994

Seizures Due to Multiple Sclerosis:Seven Patients with MRI Correlations
JNNP 56:1317-1320, Thompson,A.J.,et al, 1993



Showing articles 1200 to 1250 of 5061 << Previous Next >>